May 27, 2022 – GeneTether, Inc.

GeneTether Therapeutics Announces Issuance of New US Composition of Matter Patent for its Innovative Platform Technology Focused on Gene Editing Efficiency

San Lorenzo, California and Vancouver, British Columbia – May 25, 2022

0

GeneTether Therapeutics Inc. Announces First Quarter 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – May 26, 2022

0